Medicalgorithmics (MDG) Stock Overview
Provides cardiac diagnostic solutions in Poland, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
MDG Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Medicalgorithmics S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł34.00 |
| 52 Week High | zł42.80 |
| 52 Week Low | zł16.52 |
| Beta | 0.84 |
| 1 Month Change | 6.25% |
| 3 Month Change | -13.49% |
| 1 Year Change | 93.18% |
| 3 Year Change | 177.32% |
| 5 Year Change | 49.78% |
| Change since IPO | 65.93% |
Recent News & Updates
Recent updates
A Look At The Intrinsic Value Of Medicalgorithmics S.A. (WSE:MDG)
Oct 11
Would Medicalgorithmics (WSE:MDG) Be Better Off With Less Debt?
Sep 08What Is Medicalgorithmics S.A.'s (WSE:MDG) Share Price Doing?
Aug 15Is Medicalgorithmics (WSE:MDG) A Risky Investment?
Sep 20These 4 Measures Indicate That Medicalgorithmics (WSE:MDG) Is Using Debt Reasonably Well
Jun 14Medicalgorithmics (WSE:MDG) Is Posting Solid Earnings, But It Is Not All Good News
May 04Is Medicalgorithmics (WSE:MDG) A Risky Investment?
Mar 09Shareholder Returns
| MDG | PL Medical Equipment | PL Market | |
|---|---|---|---|
| 7D | -1.4% | -0.8% | 0.6% |
| 1Y | 93.2% | 3.1% | 37.6% |
Return vs Industry: MDG exceeded the Polish Medical Equipment industry which returned 3.1% over the past year.
Return vs Market: MDG exceeded the Polish Market which returned 37.6% over the past year.
Price Volatility
| MDG volatility | |
|---|---|
| MDG Average Weekly Movement | 5.1% |
| Medical Equipment Industry Average Movement | 5.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in PL Market | 8.7% |
| 10% least volatile stocks in PL Market | 3.0% |
Stable Share Price: MDG has not had significant price volatility in the past 3 months compared to the Polish market.
Volatility Over Time: MDG's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 117 | Kris Siemionow | www.medicalgorithmics.pl |
Medicalgorithmics S.A. provides cardiac diagnostic solutions in Poland, the United States, and internationally. It offers PocketECG, an AI-driven online ECG monitoring device for long-term holter, cardiac event, and mobile cardiac telemetry analysis; Kardiobeat.ai, an AI-Driven lightweight wireless holter monitor; DeepRhythm Platform, a hardware-agnostic cloud-based software that leverages cutting-edge AI technology to detect, classify, analyze, and report ECG data; and DeepRhythmAI, a set of algorithms for heart rhythm analysis that integrates into third-party software and devices. The company also provides virtual cardiac stress test (VCAST), an AI-based medical system developed for non-invasive, clinical quantitative, and qualitative analysis of CT-scan data, to assess the hemodynamic significance of coronary artery atherosclerotic stenosis.
Medicalgorithmics S.A. Fundamentals Summary
| MDG fundamental statistics | |
|---|---|
| Market cap | zł338.39m |
| Earnings (TTM) | -zł15.38m |
| Revenue (TTM) | zł26.80m |
Is MDG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDG income statement (TTM) | |
|---|---|
| Revenue | zł26.80m |
| Cost of Revenue | zł17.86m |
| Gross Profit | zł8.94m |
| Other Expenses | zł24.32m |
| Earnings | -zł15.38m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.55 |
| Gross Margin | 33.36% |
| Net Profit Margin | -57.39% |
| Debt/Equity Ratio | 27.2% |
How did MDG perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/26 21:11 |
| End of Day Share Price | 2025/12/23 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medicalgorithmics S.A. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Adrian Kowollik | East Value Research GmbH |
| Lukasz Kosiarski | Ipopema Securities S.A. |
| Tomasz Sokolowski | Santander Brokerage Poland |